Does ESOMEPRAZOLE Cause Rebound acid hypersecretion? 2,501 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,501 reports of Rebound acid hypersecretion have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 3.3% of all adverse event reports for ESOMEPRAZOLE.
2,501
Reports of Rebound acid hypersecretion with ESOMEPRAZOLE
3.3%
of all ESOMEPRAZOLE reports
373
Deaths
291
Hospitalizations
How Dangerous Is Rebound acid hypersecretion From ESOMEPRAZOLE?
Of the 2,501 reports, 373 (14.9%) resulted in death, 291 (11.6%) required hospitalization, and 3 (0.1%) were considered life-threatening.
Is Rebound acid hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 2,501 reports have been filed with the FAERS database.
What Other Side Effects Does ESOMEPRAZOLE Cause?
Chronic kidney disease (35,281)
Acute kidney injury (18,678)
Renal failure (14,633)
End stage renal disease (10,231)
Renal injury (9,440)
Gastrooesophageal reflux disease (4,746)
Drug ineffective (4,420)
Tubulointerstitial nephritis (4,024)
Off label use (3,180)
Pain (2,898)
What Other Drugs Cause Rebound acid hypersecretion?
OMEPRAZOLE (2,350)
LANSOPRAZOLE (1,713)
PANTOPRAZOLE (1,581)
DEXLANSOPRAZOLE (1,160)
OMEPRAZOLE\SODIUM BICARBONATE (95)
RABEPRAZOLE (64)
RANITIDINE (29)
FAMOTIDINE (12)
ESOMEPRAZOLE\NAPROXEN (9)
Which ESOMEPRAZOLE Alternatives Have Lower Rebound acid hypersecretion Risk?
ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN
ESOMEPRAZOLE vs ESTAZOLAM
ESOMEPRAZOLE vs ESTRADIOL
ESOMEPRAZOLE vs ESTRADIOL CYPIONATE